| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biorestorative Therapies, Inc. (BRTX) has 2 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. BRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 187.5K | $35.6K | - | |
| VP | 171.4K | $32.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | Alstodt Lance55 | President, CEO, Cob | Buy | 2,887 | $1.96 | $5,658.52 | +1.6% | -7.4% | -20.5% | |
| Aug 31, 2023 | Silva Francisco48 | VP Of Research And Development | Buy | 4,954 | $2.22 | $10,997.88 | +3.1% | -17.7% | -25.5% | |
| Jul 27, 2023 | Broadrick Dale60 | 10% Owner | Buy | 1,000 | $2.80 | $2,800.00 | +0.3% | -36.7% | -42.8% | |
| Jul 25, 2023 | Alstodt Lance55 | President, CEO, Cob | Buy | 4,200 | $2.44 | $10,248.00 | +2.3% | -22.2% | -29.6% | |
| Mar 31, 2023 | Silva Francisco48 | VP Of Research And Development | Buy | 747 | $3.56 | $2,659.32 | +0.5% | +25.6% | -58.8% | |
| Feb 22, 2023 | Broadrick Dale60 | 10% Owner | Buy | 6,200 | $2.86 | $17,705.00 | +0.5% | +110.2% | -55.6% | |
| Feb 1, 2023 | Alstodt Lance55 | President, CEO, Cob | Buy | 400 | $3.10 | $1,241.36 | +0.2% | +33.8% | -29.9% | |
| Jan 27, 2023 | Alstodt Lance55 | President, CEO, Cob | Buy | 200 | $3.01 | $602.00 | +0.1% | +35.9% | -47.5% | |
| Jan 20, 2023 | Alstodt Lance55 | President, CEO, Cob | Buy | 200 | $3.14 | $627.00 | - | +24.5% | -48.0% | |
| Jan 18, 2023 | Alstodt Lance55 | President, CEO, Cob | Buy | 400 | $3.11 | $1,244.30 | - | +13.7% | -47.9% |